About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
Is Alset EHome International a Winner in the Real Estate Development Industry?
Shares of Alset EHome International (AEI) have surged over the past month despite home prices rising beyond the affordability of many buyers. However, can the stock continue rallying in price despite the company’s widening losses in the last quarter? Let’s find out.
Should You Buy Sea Ltd. on the Dip?
The price of Singapore-based Sea Limited’s (SE) shares soared to hit their $359.84 all-time high on September 7, following news of Shopee’s expansion in Europe. But the price has since declined. So, is it wise to buy the dip even though the company faces competition from other e-commerce players, such as Amazon (AMZN) and MercadoLibre (MELI)? Read on. Let’s find out.
Is Range Resources a Good Natural Gas Stock to Own?
Shares of natural gas company Range Resources (RRC) have surged in price over the past few months thanks to skyrocketing natural gas prices. However, after hitting its 52-week high yesterday, does the stock have further upside to deliver? Read on.
Up 345% in the Past Month, Will Aterian Continue to Rally?
Shares of Aterian (ATER) have soared more than 345% in price over the past month, due primarily to the short squeeze frenzy. However, given that the company’s losses widened in the second quarter, can its shares continue surging? Let’s find out.
Is Globalstar a Buy Under $3?
Globalstar’s (GSAT) shares have soared 83.1% in price over the past month to close Friday’s trading session at $2.60, on speculation that it might partner with Apple (AAPL). So, is the company well-positioned to continue gaining due to increasing demand for SPOT Gen4 satellite GPS messengers? Let’s find out.
Is GoHealth a Good Digital Health Stock to Buy?
While GoHealth’s (GOCO) shares have declined considerably over the past few months, it has been making several advancements with the help of its Encompass platform. So, let’s find out if it is a good idea to buy the stock on the pullback.
Does Nutanix Deserve a Place in Your Portfolio?
Cloud-based software provider Nutanix’s (NTNX) shares have rallied in price over the past few months due to investor optimism surrounding its strategic partnerships and increasing demand for the Nutanix Cloud Platform. However, is it wise to add the stock to one’s portfolio now even though the company’s losses widened in the fourth quarter? Read on.
Is Cloopen Group a Software Stock Worth Owning?
Even though China-based software company Cloopen Group’s (RAAS) top line grew substantially in the second quarter, its shares have retreated significantly in price from their $59 all-time high, which they hit on February 9. So, let’s evaluate if it is wise to bet on the stock at its current price level considering the benefits from the company’s recent acquisition of EliteCRM. Read on.
Should Enveric Biosciences be in Your Stock Portfolio?
Enveric Biosciences (ENVB) garnered significant market attention, announcing its proposed acquisition of MagicMed in May 2021. However, is it smart to bet on the stock now, as it has yet to generate revenue? Let’s find out.